Effect of Pancreatic Hormones on pro-Atrial Natriuretic Peptide in Humans

EBioMedicine

Volumn 17, Issue , 2017, Pages 88-94

  Zois, Nora E ^a   Terzic, Dijana ^a   Færch, Kristine ^b   Plomgaard, Peter ^a   Hansen, Jakob S ^a   Rossing, Peter ^b,c,d   Goetze, Jens P ^a,c,e  

^a Rigshospitalet   (Denmark)

^b STENO DIABETES CENTER   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e MAYO CLINIC   (United States)

Author keywords

Hyperglycemia; Insulin resistance; Metabolism; Prediabetes; ProANP

Indexed keywords

ATRIAL NATRIURETIC FACTOR; GLUCAGON; GLUCOSE; INSULIN; OBINEPITIDE; GLUCOSE BLOOD LEVEL; MIDREGIONAL PRO-ATRIAL NATRIURETIC PEPTIDE, HUMAN;

ADULT; ARTICLE; BED REST; BODY MASS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLUCAGONEMIA; HYPERINSULINEMIA; HYPERINSULINEMIC-EUGLYCEMIC CLAMP TECHNIQUE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NORMAL HUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; YOUNG ADULT; ADVERSE EFFECTS; BLOOD; CLINICAL TRIAL; METABOLISM;

ADULT; ATRIAL NATRIURETIC FACTOR; BED REST; BLOOD GLUCOSE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE;

EID: 85014088157     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2017.02.026     Document Type: Article

References (37)

1. Ahrén, B., Beta- and alpha-cell dysfunction in subjects developing impiared glucose tolerance: outcome of a 12-year prospective study in postmenopausal Caucasian women. Diabetes 58 (2009), 726–731.
2. Arora, P., Wu, C., Hamid, T., Arora, G., Agha, O., Allen, K., Tainsh, R.E.T., Hu, D., Ryan, R.A., Domian, I.J., Buys, E.S., Bloch, D.B., Prabhu, S.D., Bloch, K.D., Newton-Cheh, C., Wang, T.J., Acute metabolic influences on the natriuretic peptide system in humans. J. Am. Coll. Cardiol. 67 (2016), 804–812.
3. Biensø, R.S., Ringholm, S., Kiilerich, K., Aachmann-Andersen, N.J., Krogh-Madsen, R., Guerra, B., Plomgaard, P., Van Hall, G., Treebak, J.T., Saltin, B., Lundby, C., Calbet, J.A.L., Pilegaard, H., Wojtaszewski, J.F.P., GLUT4 and glycogen synthase are key players in bed rest-induced insulin resistance. Diabetes 61 (2012), 1090–1099.
4. Brubaker, P., Drucker, D.J., Structure-function of the glucagon receptor family of G-protein-coupled receptors: the glucagon, GIP, GLP-1, and GLP-2 receptors. Recept. Channels 8 (2002), 179–188.
5. Clark, B., Sclater, A., Epstein, F., Elahi, D., Effect of glucose, insulin, and hypertonicity on atrial natriuretic peptide levels in man. Metabolism 42 (1993), 224–228.
6. Clerico, A., Del Ry, S., Giannessi, D., Measurement of cardiac natriuretic hormones (atrial natriuretic peptide, brain natriuretic peptide, and related peptides) in clinical practice: the need for a new generation of immunoassay methods. Clin. Chem. 46 (2000), 1529–1539.
7. Coué, M., Badin, P.-M., Vila, I.K., Laurens, C., Louche, K., Marquès, M.-A., Bourlier, V., Mouisel, E., Tavernier, G., Rustan, A.C., Galgani, J.E., Joanisse, D.R., Smith, S.R., Langin, D., Moro, C., Defective natriuretic peptide receptor signaling in skeletal muscle links obesity to type 2 diabetes. Diabetes 64 (2015), 4033–4045.
8. Davidson, N., Coutie, W., Strunthers, A., N-terminal proatrial natriuretic peptide and brain natriuretic peptide are stable for up to 6 h in whole blood in vitro. Circulation 91 (1995), 1276–1277.
9. Færch, K., Vistisen, D., Pacini, G., Torekov, S.S., Johansen, N.B., Witte, D.R., Jonsson, A., Pedersen, O., Hansen, T., Lauritzen, T., Jørgensen, M.E., Ahrén, B., Holst, J.J., Insulin resistance is accompanied by increased fasting glucagon and delayed glucagon suppression in individuals with normal and impaired glucose regulation. Diabetes 65 (2016), 3473–3481.
10. Færch, K., Vaag, A., Holst, J.J., Glümer, C., Pedersen, O., Borch-Johnsen, K., Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action. Diabetologia 51 (2008), 853–861.
11. Gammeltoft, S., Van Obberghen, E., Protein kinase activity of the insulin receptor. Biochem. J. 235 (1986), 1–11.
12. Gans, R.O.B., Bilo, H.J.G., Donker, A.J.M., The renal response to exogenous insulin in non-insulin-dependent diabetes mellitus in relation to blood pressure and cardiovascular hormonal status. Nephrol. Dial. Transplant. 11 (1996), 794–802.
13. Gauquelin, G., Maillet, A., Allevard, A.M., Sigaudo, D., Gharib, C., Early and late renin and ANP modifications induced by bedrest. J. Gravit. Physiol. 2 (1995), P56–P57.
14. Gauquelin, G., Maillet, A., Allevard, A.M., Sigaudo, D., Gharib, C., Diurnal rhythms of plasma renin activity, atrial natriuretic peptide and arterial pressure during head-down bed rest in humans. Eur. J. Appl. Physiol. Occup. Physiol. 73 (1996), 536–543.
15. Goetze, J.P., Plasma proANP decreases after meal intake. Clin. Chem. 59 (2013), 1270–1271.
16. Guerra, B., Ponce-González, J.G., Morales-Alamo, D., Guadalupe-Grau, A., Kiilerich, K., Fuentes, T., Ringholm, S., Biensø, R.S., Santana, A., Lundby, C., Pilegaard, H., Calbet, J.A.L., Leptin signaling in skeletal muscle after bed rest in healthy humans. Eur. J. Appl. Physiol. 114 (2014), 345–357.
17. Hall, C., Aaberge, L., Stokke, O., In vitro stability of N-terminal proatrial natriuretic factor in unfrozen samples: an important prerequisite for its use as a biochemical parameter of atrial pressure in clinical routine. Circulation, 91, 1995, 911.
18. Hansen, J.S., Clemmesen, J.O., Secher, N.H., Hoene, M., Drescher, A., Weigert, C., Pedersen, B.K., Plomgaard, P., Glucagon-to-insulin ratio is pivotal for splanchnic regulation of FGF-21 in humans. Mol. Metab. 4 (2015), 551–560.
19. Jujić, A., Nilsson, P.M., Persson, M., Holst, J.J., Torekov, S.S., Lyssenko, V., Groop, L., Melander, O., Magnusson, M., Atrial Natriuretic Peptide in the high normal range is associated with lower prevalence of insulin resistance. J. Clin. Endocrinol. Metab. 101 (2016), 1372–1380.
20. Jørgensen, T., Borch-Johnsen, K., Thomsen, T.F., Ibsen, H., Glümer, C., Pisinger, C., A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. Eur. J. Cardiovasc. Prev. Rehabil. 10 (2003), 377–386.
21. Kiilerich, K., Ringholm, S., Biensø, R.S., Fisher, J.P., Iversen, N., van Hall, G., Wojtaszewski, J.F.P., Saltin, B., Lundby, C., Calbet, J.A.L., Pilegaard, H., Exercise-induced pyruvate dehydrogenase activation is not affected by 7 days of bed rest. J. Appl. Physiol. 111 (2011), 751–757.
22. Kovacova, Z., Tharp, W.G., Liu, D., Wei, W., Xie, H., Collins, S., Pratley, R.E., Adipose tissue natriuretic peptide receptor expression is related to insulin sensitivity in obesity and diabetes. Obesity 24 (2016), 820–828.
23. Maillet, A., Pavy-Le Traon, A., Allevard, A.M., Sigaudo, D., Hughson, R.L., Gharib, C., Gauquelin, G., Hormone changes induced by 37.5-h head-down tilt (− 6 degrees) in humans. Eur. J. Appl. Physiol. Occup. Physiol. 68 (1994), 497–503.
24. Matsuda, M., DeFronzo, R.A., Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22 (1999), 1462–1470.
25. Miller, J.A., Abouchacra, S., Zinman, B., Skorecki, K.L., Logan, A.G., Atrial natriuretic factor counteracts sodium-retaining actions of insulin in normal men. Am. J. Phys. 265 (1993), R584–R590.
26. Mukoyama, M., Nakao, K., Hosoda, K., Suga, S.I., Saito, Y., Ogawa, Y., Shirakami, G., Jougasaki, M., Obata, K., Yasue, H., Kambayashi, Y., Inouye, K., Imura, H., Brain natriuretic peptide as a novel cardiac hormone in humans: evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J. Clin. Invest. 87 (1991), 1402–1412.
27. Murthy, K.K., Thibault, G., Cantin, M., Contribution of blood and systemic circulation to the processing of pro- (atrial natriuretic factor). Biochem. J. 250 (1988), 665–670.
28. Nannipieri, M., Seghieri, G., Catalano, C., Prontera, T., Baldi, S., Ferrannini, E., Defective regulation and action of atrial natriuretic peptide in type 2 diabetes. Horm. Metab. Res. 34 (2002), 265–270.
29. Nelesen, R.A., Dimsdale, J.E., Ziegler, M.G., Plasma atrial natriuretic peptide is unstable under most storage conditions. Circulation 86 (1995), 463–466.
30. Ohno, Y., Suzuki, H., Yamakawa, H., Nakamura, M., Kato, Y., Saruta, T., Correlation of sodium-related factors with insulin sensitivity in young, lean, male offspring of hypertensive and normotensive subjects. J. Hum. Hypertens. 15 (2001), 393–399.
31. Perhonen, M.A., Franco, F., Lane, L.D., Buckey, J.C., Blomqvist, C.G., Zerwekh, J.E., Peshock, R.M., Weatherall, P.T., Levine, B.D., Cardiac atrophy after bed rest and spaceflight. J. Appl. Physiol. 91 (2001), 645–653.
32. Pivovarova, O., Gögebakan, Ö., Klöting, N., Sparwasser, A., Weickert, M.O., Haddad, I., Nikiforova, V.J., Bergmann, A., Kruse, M., Seltmann, A.C., Blüher, M., Pfeiffer, A.F.H., Rudovich, N., Insulin up-regulates natriuretic peptide clearance receptor expression in the subcutaneous fat depot in obese subjects: a missing link between CVD risk and obesity?. J. Clin. Endocrinol. Metab. 97 (2012), E731–E739.
33. Ringholm, S., Biensø, R.S., Kiilerich, K., Guadalupe-Grau, A., Aachmann-Andersen, N.J., Saltin, B., Plomgaard, P., Lundby, C., Wojtaszewski, J.F.P., Calbet, J.A., Pilegaard, H., Bed rest reduces metabolic protein content and abolishes exercise-induced mRNA responses in human skeletal muscle. Am. J. Physiol. Endocrinol. Metab., 301, 2011.
34. Stuart, C.A., Shangraw, R.E., Prince, M.J., Peters, E.J., Wolfe, R.R., Bed-rest-induced insulin resistance occurs primarily in muscle. Metabolism 37 (1988), 802–806.
35. Then, C., Kowall, B., Lechner, A., Meisinger, C., Heier, M., Koenig, W., Peters, A., Thiery, J., Rathmann, W., Seissler, J., Plasma MR-proANP levels are associated with carotid intima-media thickness in the general community: the KORA F4 study. Atherosclerosis 230 (2013), 235–241.
36. Trevisan, R., Fioretto, P., Semplicini, A., Opocher, G., Mantero, F., Rocco, S., Remuzzi, G., Morocutti, A., Zanette, G., Donadon, V., Perico, N., Giorato, C., Nosadini, R., Role of insulin and atrial natriuretic peptide in sodium retention in insulin-treated IDDM patients during isotonic volume expansion. Diabetes 39 (1990), 289–298.
37. Wang, T.J., Larson, M.G., Keyes, M.J., Levy, D., Benjamin, E.J., Vasan, R.S., Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals. Circulation 115 (2007), 1345–1353.